Lancashire and South Cumbria
Formulary
Formulary
13 Skin
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
13-11-02 Chlorhexidine salts
| Chlorhexidine gluconate 4% Hibiscrub® |
|
Formulary
|
Cleansing solution, 250mL, 500mL |
|
Links
Chlorhexidine anaphylaxis risk (MHRA alert)
LSCMMG: Gastroenterology Biologics Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA Drug Safety Update Dec 2014: Chlorhexidine solutions: reminder of the risk of chemical burns in premature infants
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people